Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kees

Showing results (161-170 of 376) with videos related to

Pageof 38
Sort By:
Human Mutation|November 19, 2011
Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl LevelsRoeland Huijgen, Barbara Sjouke, Kelly Vis, et al.
European Heart Journal|December 19, 2015
Heterogeneous impact of classic atherosclerotic risk factors on different arterial territories: the EPIC-Norfolk prospective population studyRobert M Stoekenbroek, S Matthijs Boekholdt, Robert Luben, et al.
Atherosclerosis|March 11, 2020
The identification and function of a Netrin-1 mutation in a pedigree with premature atherosclerosisCaroline S Bruikman, Dianne Vreeken, Huayu Zhang, et al.
International Journal of Cardiology|November 26, 2016
Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatmentRobert Dufour, Jean Bergeron, Daniel Gaudet, et al.
Circulation|April 6, 2018
Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT TrialAntonio J Vallejo-Vaz, Rana Fayyad, S Matthijs Boekholdt, et al.
Journal of Atherosclerosis and Thrombosis|December 1, 2017
Efficacy and Safety of Pitavastatin in Children and Adolescents with Familial Hypercholesterolemia in Japan and EuropeMariko Harada-Shiba, John J P Kastelein, G Kees Hovingh, et al.
Atherosclerosis|May 22, 2015
Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of CardiologyGuy De Backer, Joost Besseling, John Chapman, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohortJohn F Thompson, Craig L Hyde, Linda S Wood, et al.
Plos One|May 17, 2014
eNOS activation by HDL is impaired in genetic CETP deficiencyMonica Gomaraschi, Alice Ossoli, Silvia Pozzi, et al.
Journal of Lipid Research|February 2, 2016
Population and assay thresholds for the predictive value of lipoprotein (a) for coronary artery disease: the EPIC-Norfolk Prospective Population StudyRutger Verbeek, S Matthijs Boekholdt, Robert M Stoekenbroek, et al.
Pageof 38

Showing results (161-170 of 376) with videos related to

Sort By:
Pageof 38
Human Mutation|November 19, 2011
Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl LevelsRoeland Huijgen, Barbara Sjouke, Kelly Vis, et al.
European Heart Journal|December 19, 2015
Heterogeneous impact of classic atherosclerotic risk factors on different arterial territories: the EPIC-Norfolk prospective population studyRobert M Stoekenbroek, S Matthijs Boekholdt, Robert Luben, et al.
Atherosclerosis|March 11, 2020
The identification and function of a Netrin-1 mutation in a pedigree with premature atherosclerosisCaroline S Bruikman, Dianne Vreeken, Huayu Zhang, et al.
International Journal of Cardiology|November 26, 2016
Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatmentRobert Dufour, Jean Bergeron, Daniel Gaudet, et al.
Circulation|April 6, 2018
Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT TrialAntonio J Vallejo-Vaz, Rana Fayyad, S Matthijs Boekholdt, et al.
Journal of Atherosclerosis and Thrombosis|December 1, 2017
Efficacy and Safety of Pitavastatin in Children and Adolescents with Familial Hypercholesterolemia in Japan and EuropeMariko Harada-Shiba, John J P Kastelein, G Kees Hovingh, et al.
Atherosclerosis|May 22, 2015
Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of CardiologyGuy De Backer, Joost Besseling, John Chapman, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohortJohn F Thompson, Craig L Hyde, Linda S Wood, et al.
Plos One|May 17, 2014
eNOS activation by HDL is impaired in genetic CETP deficiencyMonica Gomaraschi, Alice Ossoli, Silvia Pozzi, et al.
Journal of Lipid Research|February 2, 2016
Population and assay thresholds for the predictive value of lipoprotein (a) for coronary artery disease: the EPIC-Norfolk Prospective Population StudyRutger Verbeek, S Matthijs Boekholdt, Robert M Stoekenbroek, et al.
Pageof 38